Phase 2 Cardiomyopathy Trial, Recruiting (NCT06564909)

Phase 2 Cardiomyopathy Trial, Recruiting NCT06564909 Sponsor: Ain Shams University Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06564909 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a male or female between the ages of 18 and 75 years old
You have had a specific type of heart attack called a STEMI and are receiving a procedure to open the blocked artery (called PCI or coronary angioplasty)

Who may not be able to join:

You have had a previous heart attack, a previous artery-opening procedure (PCI), heart bypass surgery, or any other heart surgery in the past
Your heart attack symptoms started more than 12 hours before treatment, or the artery-opening procedure was not fully successful
You were given clot-dissolving drugs or certain blood-thinning medications before your artery-opening procedure
You currently have an active infection or inflammatory condition
You have serious liver or kidney disease (confirm with trial site for specific test thresholds)
You have any form of cancer or a blood disorder
You are currently pregnant or breastfeeding
You are already taking part in another clinical trial
You are currently taking antioxidant supplements or medications
You have a known allergy or bad reaction to any of the medications used in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +201151189985

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06564909

Sponsor: Ain Shams University

Phase: Phase 2

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +201151189985

More information: https://clinicaltrials.gov/study/NCT06564909

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a male or female between the ages of 18 and 75 years old
You have had a specific type of heart attack called a STEMI and are receiving a procedure to open the blocked artery (called PCI or coronary angioplasty)

Who may not be able to join:

You have had a previous heart attack, a previous artery-opening procedure (PCI), heart bypass surgery, or any other heart surgery in the past
Your heart attack symptoms started more than 12 hours before treatment, or the artery-opening procedure was not fully successful
You were given clot-dissolving drugs or certain blood-thinning medications before your artery-opening procedure
You currently have an active infection or inflammatory condition
You have serious liver or kidney disease (confirm with trial site for specific test thresholds)
You have any form of cancer or a blood disorder
You are currently pregnant or breastfeeding
You are already taking part in another clinical trial
You are currently taking antioxidant supplements or medications
You have a known allergy or bad reaction to any of the medications used in this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Ain Shams University

Registry

ClinicalTrials.gov

Start date

1 June 2025

Est. completion

1 February 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Evaluation of the marker nitrotyrosine; Evaluation of the marker (MMP-2)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov